Article Details
Retrieved on: 2021-08-31 14:03:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial will enroll about 4,000 people worldwide to confirm the drug's safety and immunogenicity profiles, specifically when compared to rival AstraZeneca/ ...
Article found on: www.biospace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here